Valve-in-Valve TAVR versus Redo Surgical Aortic Valve Replacement: Early Outcomes.

Amila CizmicElmar KuhnKaveh Eghbalzadeh Carolyn WeberParwis Baradaran RahmanianMatti AdamVictor MauriTanja RudolphStephan BaldusThorsten Wahlers

Published in: The Thoracic and cardiovascular surgeon (2021)

ViV-TAVR can be a safe and feasible alternative treatment option in patients with degenerated aortic valve bioprosthesis. The choice of treatment should include the patient's individual characteristics considering ViV-TAVR as a standard of care.

Keyphrases

aortic valve
aortic valve replacement
aortic stenosis
transcatheter aortic valve replacement
transcatheter aortic valve implantation
ejection fraction
healthcare
palliative care
coronary artery disease
metabolic syndrome
skeletal muscle
pain management
adipose tissue
atrial fibrillation